The article summarizes data on lipid peroxidation as the main cause of atherosclerosis and, subsequently, heart desease. Prooxidative and anti-oxidative systems’ functionality under normal conditions and with myocardial ischemia is described. Medications used to normalize myocardial metabolism are listed, characterized and classified. The article also discusses experimental and clinical data (including own researches) on using a new cytoprotector Mexicor in circulatory system pathology.
